ADNT vs PSNY

The Advanced Deterministic Scorecard reveals critical weaknesses in Adient plc's financial health, with a Piotroski F-Score of just 2/9 indicating severe operational and profitability concerns. Despite a low forward P/E of 7.11 and a price/book below 1, suggesting potential value, the company is unprofitable (negative net margin and ROE), highly leveraged (Debt/Equity of 1.23), and experiencing sharply declining earnings (YoY EPS down 23.5%, earnings growth -76.6%). Insider selling, inconsistent earnings beats (only 1 of last 4 quarters), and weak long-term price performance (-47.7% over 3 years) further undermine confidence. While analysts recommend a 'buy' with a $25.05 target, the fundamental fragility outweighs near-term optimism.

PSNY exhibits severe financial distress, anchored by a weak Piotroski F-Score of 3/9 and a critical liquidity crisis evidenced by a Current Ratio of 0.43. The company is operating with negative equity (Price/Book: -0.30) and catastrophic profit margins of -105.95%, indicating that costs are vastly outpacing revenue generation. While YoY revenue growth remains positive at 26.10%, the accelerating EPS decline (-416.7% Q/Q) and a 0/100 technical trend signal a high risk of insolvency or significant shareholder dilution.